|
Hyperthyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
Thyroid abnormalities were detected in 45 (52.3%) patients, including 28 (32.3%) hypothyroidism, 3 (3.5%) hyperthyroidism and 20 (23.3%) thyroperoxidase antibody positivity.
|
31780218 |
2019 |
|
Hyperthyroidism
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In conclusion, the presence of DIO2 peptide antibodies is connected to Graves' hyperthyroidism influencing the levels of antibodies against TPO, Tg and TSH receptor, as well as the therapeutic efficacy of antithyroid drugs.
|
30610492 |
2019 |
|
Hyperthyroidism
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Genomewide significant variants were used as instruments for standardized FT4 and thyrotropin levels within the reference range, standardized triiodothyronine (FT3):FT4 ratio, hypothyroidism, standardized thyroid peroxidase antibody levels, and hyperthyroidism.
|
30673084 |
2019 |
|
Hyperthyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
We reviewed administrative data on 174011 patients with TSH measured at a tertiary referral center between 2011 and 2017 to identify individuals with hyperthyroidism (TSH <0.05 mU/L) and their subsequent outcomes: evaluation (measurement of T4, T3, radioactive iodine (RAI) uptake scan, thyroid-stimulating immunoglobulin, thyroid peroxidase antibodies) diagnosis, referral and treatment.
|
30004926 |
2018 |
|
Hyperthyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our meta-analysis suggests that TPO-Ab positivity, hypothyroidism and hyperthyroidism might be associated with prevalent psoriatic disease.
|
28747386 |
2017 |
|
Hyperthyroidism
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Blood examinations showed hyperthyroidism (thyroid-stimulating hormone ≤.010 µU/mL; free T3 ≥25.0 pg/mL; free T4 ≥8.0 ng/dL) and elevation of antithyroid antibody levels (thyroid peroxidase antibody, 87 IU/mL).
|
27919794 |
2017 |
|
Hyperthyroidism
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Graves' ophthalmopathy is characterized by hyperthyroidism, which is associated with higher serum T<sub>3</sub> levels than T<sub>4</sub> due to deiodinase enzymes.The effect of Graves' patient's sera (n=52) with elevated thyroid hormone and TSH receptor or thyroid peroxidase antibody (anti-TPO) levels was investigated on thyroidal, skeletal and eye muscle type 2 deiodinase enzyme (DII) activities.
|
28750432 |
2017 |
|
Hyperthyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
This case illustrates the necessity to analyse patients with hyperthyroidism accompanied by diffuse (99 m)Tc uptake and negative TPO, TSHR, and thyroglobulin antibodies for TSHR germline mutations.
|
22763653 |
2012 |
|
Hyperthyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
The prevalence of thyroid peroxidase-Ab was higher in both hypothyroid and hyperthyroid cases than in controls.
|
20956436 |
2011 |
|
Hyperthyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
Hypothyroid PPT patients were more often thyroid autoantibody-positive (P<0.005) and the TPO antibody median value was higher compared to hyperthyroid PPT patients (500 and 32 U/ml, P<0.0001).
|
20408864 |
2010 |
|
Hyperthyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
Hyperthyroidism in Graves' disease is caused by thyroid-stimulating autoantibodies to the TSH receptor (TSHR), whereas hypothyroidism in Hashimoto's thyroiditis is associated with thyroid peroxidase and thyroglobulin autoantibodies.
|
17823263 |
2007 |
|
Hyperthyroidism
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Post partum thyroiditis occurs in 50% of TPO AB+ve women and is characterised by transient hyperthyroidism followed by transient hypothyroidism during the first six months, post partum.
|
12389641 |
2002 |
|
Hyperthyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
There was no correlation between reactivity to D1 and either clinical measures of hyperthyroidism or antibody titers to thyroid peroxidase or thyroglobulin.
|
8345048 |
1993 |